EXABLATE

Mr-guided Focused Ultrasound System

FDA Premarket Approval P150038

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the exablate model 4000 type 1. 0 system (exablate neuro). This device is indicated for use in the unilateral thalamotomy treatment of idiopathic essential tremor patients with medication-refractory tremor. Patients must be at least age 22. The designated area in the brain responsible for the movement disorder symptoms (ventralis intermedius) must be identified and accessible for targeted thermal ablation by the exablate device.

DeviceEXABLATE
Classification NameMr-guided Focused Ultrasound System
Generic NameMr-guided Focused Ultrasound System
ApplicantInSightec
Date Received2015-10-21
Decision Date2016-07-11
Notice Date2016-07-25
PMAP150038
SupplementS
Product CodePOH
Docket Number16M-2183
Advisory CommitteeNeurology
Expedited ReviewNo
Combination Product No
Applicant Address InSightec 5 Nahum Heth Street tirat-hacarmet 39120
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150038Original Filing
S024 2022-10-12 Normal 180 Day Track No User Fee
S023 2022-08-05 Real-time Process
S022
S021 2022-03-10 Real-time Process
S020 2022-03-08 30-day Notice
S019
S018
S017
S016
S015
S014 2021-03-31 Panel Track
S013 2020-10-23 Normal 180 Day Track
S012 2019-08-08 Normal 180 Day Track
S011 2019-03-26 30-day Notice
S010
S009
S008 2018-07-23 Normal 180 Day Track
S007 2018-04-23 30-day Notice
S006 2018-03-07 Panel Track
S005 2018-02-20 Normal 180 Day Track
S004 2017-08-16 Normal 180 Day Track No User Fee
S003 2017-03-28 Normal 180 Day Track
S002 2017-01-17 Normal 180 Day Track
S001 2016-08-03 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
07290019402466 P150038 023
07290019402442 P150038 023

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.